Funding for this research was provided by:
Teva Pharmaceutical Industries
Received: 26 June 2020
Accepted: 18 August 2020
First Online: 4 September 2020
Ethics approval and consent to participate
: The survey, informed consent document, and all other relevant patient materials were approved by a central institutional review board (Quorum). All participating patients provided informed consent.
: Not applicable.
: DCB has received grant support and honoraria from Allergan, Amgen, Avanir, Biohaven, Lilly, Promius, and Teva Pharmaceuticals. She is on the editorial board of <i>Current Pain and Headache Reports</i>. RPC has received consulting fees and honoraria from Teva Pharmaceuticals, Amgen, Alder, and Lilly. SKG, JMC, VR-C, and RY are employees of Teva Pharmaceuticals. BC had no conflicts of interest to report.